Top news from across the health care landscape.
Treating depression could yield better cardiovascular results, according to HCP Live. A research team at Huazhong University of Science and Technology examined whether depression is linked to the risk of all-cause and cardiovascular disease mortality in Chinese adults. Their findings highlight the importance and urgency of depression management as a measure for preventing premature deaths in China.
Misinformation and limited clinician communication around the risk of human papillomavirus (HPV) among men who have sex with men (MSM) are some barriers to vaccination, according to Contagion Live. A study team conducted semi-structured interviews with 38 MSM living in New York City between 24 and 27 years of age in order to evaluate knowledge and communication around HPV. The results indicate that young MSM have mixed knowledge around HPV, including a widespread sense that vaccination is only necessary for women.
Researchers have found a potential pathway to stop bortezomib resistance in patients with multiple myeloma (MM), according to The American Journal of Managed Care. The study authors noted that induced expression of PH domain leucine-rich repeat protein phosphatase (PHLPP) may boost bortezomib sensitivity in MM cells by activating the autophagy pathway. Further research may benefit from the exploration of interactions between PHLPP, protein kinase B, and the protein complex NF-κB, and these interactions may have implications for cell apoptosis in patients with MM.
As a pharmacist, your insight has a direct effect on patient outcomes. Help drive medicine forward with your opinions. Participate in a quick survey of OTC products for a chance to win a $1,000 Visa gift card. Vote now by clicking here: https://hraresearchnetwork.com/wix/p6499706.aspx?hPTsource=5